Retractable Technologies (Retractable Technologies) LT-Debt-to-Total-Asset

: 0.01 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Retractable Technologies's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.01.

Retractable Technologies's long-term debt to total assets ratio declined from Dec. 2022 (0.01) to Dec. 2023 (0.01). It may suggest that Retractable Technologies is progressively becoming less dependent on debt to grow their business.

Retractable Technologies LT-Debt-to-Total-Asset Historical Data

The historical data trend for Retractable Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Retractable Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.06

0.03

0.01

Retractable Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.01

Retractable Technologies LT-Debt-to-Total-Asset Calculation

Retractable Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	1.234	/	179.672
	=	0.01

Retractable Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	1.234	/	179.672
	=	0.01

Retractable Technologies (AMEX:RVP) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Retractable Technologies LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Retractable Technologies's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Retractable Technologies (Retractable Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Retractable Technologies Inc (AMEX:RVP) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

511 Lobo Lane, Little Elm, TX, USA, 75068-5295

Website

https://www.retractable.com

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to its other products.

Executives

Thomas J Shaw	director, 10 percent owner, officer: President and CEO	511 LOBO LANE, LITTLE ELM TX 75068
Braden Michael Leonard	10 percent owner	156 S. FIRST STREET, ZIONSVILLE IN 46077
Bigby Walter O Jr	director	816 BENTON RD, BOSSIER CITY LA 71111
Darren E Findley	director	1618 GRASSMERE RD, FRANKLIN TN 37064
Russell B Kuhlman	director, officer: Vice President of Sales	511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Fort John W Iii	director, officer: Chief Financial Officer	511 LOBO LANE, LITTLE ELM TX 75068
Amy Mack	director	1701 LEGACY DRIVE SUITE 100, FRISCO TX 75034
Clarence D Zierhut	director	1217 BLUEBIRD LANE, GARLAND TX 75042
Lillian E Salerno	10 percent owner	777 7TH AVENUE, UNIT 308, WASHINGTON DC 20001
Suzanne M August	10 percent owner	340 NORTH JULIA CIRCLE, ST. PETERSBURG FL 33706
Steven R Wisner	director, officer: Exec. VP, Eng & Prod.	511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Marco Laterza	director	P.O. BOX 64104, EL PASO TX 79904
Jimmie Shiu	director	511 LOBO LANE, P.O. BOX 9, LITTLE ELM TX 75068
Patti King	director	9145 MARTIN ROAD, ROSWELL GA 30076
Michele Larios	officer: Vice President/General Counsel	511 LOBO LANE, LITTLE ELM TX 75068

Retractable Technologies (Retractable Technologies) Headlines

From GuruFocus

Is Retractable Technologies (RVP) Modestly Undervalued? A Comprehensive Analysis

By GuruFocus Research • 08-22-2023

Retractable Technologies Inc (RVP) CEO Thomas J Shaw buys 200,000 Shares

By gurufocus • 03-16-2009